Geography: Business headquartered in German-speaking countries (DACH region)
Development status: Market-ready products, e.g. first sales, accepted prototypes and test customers, clinical trial data available
Sales potential: Reachable market > 250 million euros worldwide, growth > 5% p.a.; market and product advantages allow rapid sales growth: industrial size (>10 million euros) achievable in five years; innovation-driven market with high potential customer benefits; customer demand already exists
Result potential: cash break-even promptly achievable, ideally in two to three years
Industry: Life sciences
- Medical technology
- Diagnostics
- Biotech/Pharma (no drug development)
- Applied technologies
- We do not invest in research or development institutes
Management: Excellent staffing in terms of the product and technology side; other core functions adequately filled or, if required, promptly filled